A retrospective study included 11 patients with T1D with detectable C‐peptide and positive glutamic acid decarboxylase (GAD) who were treated consecutively with GLP‐1RAs alongside insulin (nine patients had liraglutide, two patients had dulaglutide).114. This evidence concerns the gene INS and type 1 diabetes mellitus.